1
0
0
News
Affinity-Tuned CAR T Cells Slay Tumor Cells, Spare Normal Cells
www.genengnews.com
Get the latest in biotechnology through daily news coverage as well as analysis, features, tutorials, webinars, podcasts, and blogs. Learn about the entire...
Expanding Immunotherapy to More Cancer Types - NCI
www.cancer.gov
Engineering immune cells to have a decreased affinity for their targets on cancer cells may not weaken their efficacy but may reduce the risk of side effects.
Telephone & Addresses
Yangbing Zhao, 50, Daly City, Poncetta Dr
View Yangbing's social profiles and photos on Facebook, MySpace, and +40 Networks.
Yangbing S Zhao, 51, Lumberton, Gladiola Ln
View Yangbing's social profiles and photos on Facebook, MySpace, and +40 Networks.
WhitePages: Yangbing Zhao | Whitepages
4 matches for Yangbing Zhao. Find Yangbing Zhao's phone, address, etc. on Whitepages, the most trusted online directory."
Interests
Yangbing Zhao - Patent Inventor
www.freshpatents.com
List of recent Yangbing Zhao patent applications
Business Profiles
Researchgate: Yangbing Zhao
Philadelphia, PA, United States
patentbuddy: Yangbing Zhao
Rockville, MD, US
Books & Literature
Experimental and Applied Immunotherapy - Google Books
books.google.co.il
Immunotherapy is now recognized as an essential component of treatment for a wide variety of cancers. It is an interdisciplinary field that is critically...
AACR 2016: Abstracts American Association for Cancer...
books.google.nl
The AACR Annual Meeting is a must-attend event for cancer researchers and the broader cancer community. This year's theme, "Delivering Cures Through...
Related Documents
CiteSeerX — Extrathymic Generation of Tumor-Specific T Cells from...
citeseerx.ist.psu.edu
BibTeX @MISC{Zhao_extrathymicgeneration, author = {Yangbing Zhao and Maria R. Parkhurst and Zhili Zheng and Cyrille J. Cohen and John P. Riley and Luca Gattinoni and
EBSCOhost | | Recognition of Tumor Antigens by In Vitro...
web.a.ebscohost.com
Yangbing Zhao,1 Zhili Zheng,1 Cyrille J. Cohen,1 Steven A. Rosenberg,1 Richard A. Morgan.1. 1Surgery Branch, National Cancer Institute, Bethesda, MD.
EBSCOhost | | High-Efficiency Transfection of Primary Human...
web.b.ebscohost.com
Yangbing Zhao, Zhili Zheng, Cyrille J. Cohen, Luca Gattinoni, Douglas C. Palmer,. Nicholas P. Restifo, Steven A. Rosenberg, and Richard A.
Scientific Publications
Construction and Pre-clinical Evaluation of an Anti-CD19 Chimeric...
www.ncbi.nlm.nih.gov
James N. Kochenderfer, * Steven A. Feldman, * Yangbing Zhao, * Hui Xu, * Mary A. Black, * Richard A. Morgan, * Wyndham H. Wilson, Ψ and Steven A. Rosenberg*
Publications
Publications Authored by Yangbing Zhao | PubFacts
www.pubfacts.com
Publications Authored by Yangbing Zhao
Engineered T cells for cancer therapy | SpringerLink
link.springer.com
It is now well established that the immune system can control and eliminate cancer cells. Adoptive T cell transfer has the potential to overcome the signif
High-affinity TCRs generated by phage display provide CD4+ T cells...
www.pubfacts.com
PubFacts seeks to make the world's scientific research easy to locate, access, and collaborate on.
Video & Audio
Yangbing Zhao - YouTube
www.youtube.com
Teile deine Videos mit Freunden, Verwandten oder der ganzen Welt
Reports & Statements
4th International Biologics Innovation Forum – SAPA-GP
sapa-gp.org
... Professor, Kaohsiung Medical University; Weikang Tao, CEO of Shanghai Hengrui; Yangbing Zhao, Director, T Cell Engineering Lab (TCEL), ...
Miscellaneous
Yangbing Zhao | LinkedIn
www.linkedin.com
View Yangbing Zhao's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Yangbing Zhao discover ...
Yangbing Zhao | LinkedIn
www.linkedin.com
A scientist in the field of cancer immunotherapy, especially in T cell based gene and adoptive cell therapies. Director, T Cell Engineering Lab (TCEL),Adjunct Associate Professor The main mission of TCEL is to develop genetically engineered T lymphocyte adoptive immunotherapy into ...
WO A3 - Method of enhancing cd4+ t cell responses
patents.google.com
Inventors, Eli Gilboa, Yangbing Zhao. Applicant, Eli Gilboa, Univ Duke, Yangbing Zhao. Export Citation, BiBTeX, EndNote, RefMan. Classifications (15), Legal ...
A Herceptin-Based Chimeric Antigen Receptor with Modified Signaling...
www.jimmunol.org
Yangbing Zhao *, Qiong J. Wang *, Shicheng Yang *, James N. Kochenderfer*
Recognition of Tumor Antigens by In Vitro Developed T Cells from...
www.infona.pl
Yangbing Zhao, Zhili Zheng, Cyrille J. Cohen, Steven A. Rosenberg, Richard A. Morgan · Details · Authors · Fields ... Yangbing Zhao. Surgery Branch, National ...
High-Affinity TCRs Generated by Phage Display Provide CD4+ T Cells...
www.jimmunol.org
Yangbing Zhao *, Alan D. Bennett †
Engineered T cells for cancer therapy | Read by QxMD
read.qxmd.com
Carl H June, Marcela V Maus, Gabriela Plesa, Laura A Johnson, Yangbing Zhao, Bruce L Levine, Stephan A Grupp, David L Porter. Cancer Immunology ...
Construction and preclinical evaluation of an anti-CD19 chimeric...
read.qxmd.com
James N Kochenderfer, Steven A Feldman, Yangbing Zhao, Hui Xu, Mary A Black, Richard A Morgan, Wyndham H Wilson, Steven A Rosenberg. Journal of ...
Frontiers in Cancer Immunology:: volume 1 | Bentham Science
www.eurekaselect.com
arrow img PDF Price: $30. Targeting T Cell Costimulation; arrow img Author(s): Yangbing Zhao arrow img DOI: arrow img ...
Immunotherapy with Car T Cells - Carl June
grantome.com
See 4 grants from Yangbing Zhao · See grants from University of Pennsylvania. Abstract; Funding; Institution; Related projects; Publications; Comments ...
JCI - Gene therapy using genetically modified lymphocytes targeting...
www.jci.org
Dhanalakshmi Chinnasamy,1 Zhiya Yu,1 Marc R. Theoret,1Yangbing Zhao,1,2 Rajeev K. Shrimali,1 Richard A. Morgan,1 Steven A. Feldman,1 ...
MIATA | MIATA cited
miataproject.org
... Chew, Yangbing Zhao, Bruce L. Levine, Steven M. Albelda, Michael Kalos, and Carl H. June, CANCER IMMUNOL RES, 2014, EPub, doi:
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is...
mdanderson.elsevierpure.com
Jennifer A. Wargo ; Paul F. Robbins ; Yong Li ; Yangbing Zhao ; Mona El-Gamil ; Diana Caragacianu ; Zhili Zheng ; Julie A. Hong ; Stephanie Downey ; David S.
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is...
www.infona.pl
Yangbing Zhao. National Institutes of Health, Surgery Branch, Center for Cancer Research, National Cancer Institute,... see all ...
TCR affinity and specificity requirements for human regulatory T-cell...
experts.umn.edu
... Nathaniel Liddy ; Alan D. Bennett ; Jessie Gavarret ; Annelise Vuidepot ; Yangbing Zhao ; Bruce R. Blazar ; Bent K. Jakobsen ; James L. Riley.
Chapter - Targeting T Cell Costimulation | Bentham Science
www.eurekaselect.com
Targeting T Cell Costimulation. Pp (30). Yangbing Zhao. Abstract. T lymphocytes can be modified by gene transfer to enhance their anti-tumor activities ...
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of...
www.investorvillage.com
Alaunos The…utics, Inc. Message board - Online Community of active, educated investors researching and discussing Alaunos The…utics, Inc. Stocks.
University of Pennsylvania Pledges $5 Million to Company Cofounded by...
cprlaw.com
It is not common for Penn Medicine – which includes the University of Pennsylvania Health System and the Perelman School of Medicine – to make monetary
Related search requests for Yangbing Zhao
|
Person "Zhao" (7) Forename "Yangbing" (2) Name "Zhao" (5576) |
sorted by relevance / date